Tag

Advertisement

drug-2

BioInvent presents positive Phase 1 data

December 8, 2023

BioInvent International has presented the …

Jeroen Rovers

Mendus and Australasian Leukaemia & Lymphoma Group expand collaboration

December 6, 2023

Mendus has entered into a …

Abera Bioscience reports toxicology study results

December 5, 2023

Abera Bioscience has concluded the …

AstraZeneca to discontinue Phase III trials

December 4, 2023

AstraZeneca has decided to discontinue …

Valo Therapeutics receives regulatory approval to expand Phase I trial

November 29, 2023

Valo Therapeutics received approval from …

Alzinova announces positive phase 1b results

November 29, 2023

Alzinova has reported positive top-line …

Scandion Oncology reports final Phase IIa data

November 22, 2023

The company has announced data …

Herantis Pharma announces positive Phase 1a data

November 15, 2023

The company has announced positive …

FluoGuide announces Phase IIb results

November 15, 2023

FluoGuide has reported positive topline …

FluoGuide announces Phase IIa results

November 7, 2023

The company has announced topline …

Positive data from TILT Biotherapeutics

November 7, 2023

The company has presented Phase …

Multiple issues need further investigation in SynAct trial

November 2, 2023

SynAct Pharma has announced evaluation …

Aqilion reports positive Phase I results

October 31, 2023

The company has reported results …

Spago Nanomedical to initiate phase I/IIa study in Australia

October 23, 2023

The company’s application to start …

Carlos de Sousa

Ultimovacs announces NIPU results presented at ESMO 2023

October 18, 2023

Ultimovacs has announced the results …

New results from Hansa Biopharma’s Imlifidase study

October 17, 2023

The company has announced results …

1
2
3
···
5